Home › Compare › LSBPW vs ORCC

LSBPW vs ORCC: Dividend Comparison 2026

LSBPW yields 19607.84% · ORCC yields 9.79%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 LSBPW wins by $43116657640611241984.00M in total portfolio value
10 years
LSBPW
LSBPW
● Live price
19607.84%
Share price
$0.01
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$43116657640611241984.00M
Annual income
$42,688,387,590,704,500,000,000,000.00
Full LSBPW calculator →
ORCC
ORCC
● Live price
9.79%
Share price
$13.48
Annual div
$1.32
5Y div CAGR
-50%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$21.4K
Annual income
$1.04
Full ORCC calculator →

Portfolio growth — LSBPW vs ORCC

📍 LSBPW pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodLSBPWORCC
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, LSBPW + ORCC cover 0 of 12 months — good coverage

Jan
—
Feb
—
Mar
—
Apr
—
May
—
Jun
—
Jul
—
Aug
—
Sep
—
Oct
—
Nov
—
Dec
—
LSBPW pays
ORCC pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

LSBPW
Annual income on $10K today (after 15% tax)
$1,666,666.67/yr
After 10yr DRIP, annual income (after tax)
$36,285,129,452,098,824,000,000,000.00/yr
ORCC
Annual income on $10K today (after 15% tax)
$832.34/yr
After 10yr DRIP, annual income (after tax)
$0.88/yr
At 15% tax rate, LSBPW beats the other by $36,285,129,452,098,824,000,000,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of LSBPW + ORCC for your $10,000?

LSBPW: 50%ORCC: 50%
100% ORCC50/50100% LSBPW
Portfolio after 10yr
$21558328820305620992.00M
Annual income
$21,344,193,795,352,250,000,000,000.00/yr
Blended yield
99.01%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on ORCC right now

LSBPW
No analyst data
Altman Z
-2.9
Piotroski
2/9
ORCC
Analyst Ratings
9
Buy
4
Hold
1
Sell
Consensus: Buy
Price Target
$16.00
+18.7% upside vs current
Range: $16.00 — $16.00
Altman Z
0.5
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

LSBPW buys
0
ORCC buys
0
No recent congressional trades found for LSBPW or ORCC in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricLSBPWORCC
Forward yield19607.84% ✓9.79%
Annual dividend / share$2.00 ✓$1.32
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0% ✓-50%
Portfolio after 10y$43116657640611241984.00M ✓$21.4K
Annual income after 10y$42,688,387,590,704,500,000,000,000.00 ✓$1.04
Total dividends collected$43088394752836018176.00M ✓$1.0K
Payment frequencyquarterlyquarterly
SectorStockBDC

Year-by-year: LSBPW vs ORCC ($10,000, DRIP)

YearLSBPW PortfolioLSBPW Income/yrORCC PortfolioORCC Income/yrGap
1← crossover$1,971,484$1,960,784.31$11,190$489.61+$1.96M → LSBPW
2$363,385,705$361,276,216.55$12,229$256.01+$363.37M → LSBPW
3$62,623,165,419$62,234,342,714.74$13,216$130.74+$62623.15M → LSBPW
4$10,090,370,899,857$10,023,364,112,859.02$14,207$66.02+$10090370.89M → LSBPW
5$1,520,188,000,252,008$1,509,391,303,389,160.20$15,234$33.17+$1520188000.24M → LSBPW
6$214,150,725,551,759,100$212,524,124,391,489,440.00$16,317$16.62+$214150725551.74M → LSBPW
7$28,209,076,706,944,060,000$27,979,935,430,603,678,000.00$17,468$8.32+$28209076706944.05M → LSBPW
8$3,474,731,797,968,986,000,000$3,444,548,085,892,556,000,000.00$18,695$4.16+$3474731797968986.00M → LSBPW
9$400,252,383,090,414,000,000,000$396,534,420,066,587,160,000,000.00$20,006$2.08+$400252383090414016.00M → LSBPW
10$43,116,657,640,611,245,000,000,000$42,688,387,590,704,500,000,000,000.00$21,407$1.04+$43116657640611241984.00M → LSBPW

LSBPW vs ORCC: Complete Analysis 2026

LSBPW — Stock

LakeShore Biopharma Co., Ltd., a biopharmaceutical company, engages in discovering, developing, manufacturing, and commercializing of vaccines and therapeutic biologics for infectious diseases and cancer. The company develops a proprietary PIKA immunomodulating technology platform and a series of product targeting PIKA rabies vaccine, PIKA recombinant COVID-19 vaccine, and PIKA YS-ON-001. It operates in China, the United States, Singapore, the United Arab Emirates, and the Philippines. The company was formerly known as YS Biopharma Co., Ltd. and changed its name to LakeShore Biopharma Co., Ltd in May 2024. LakeShore Biopharma Co., Ltd was founded in 2002 and is based in Beijing, China.

Full LSBPW Calculator →

ORCC — BDC

Owl Rock Capital Corporation is a business development company. The fund makes investments in senior secured or unsecured loans, subordinated loans or mezzanine loans and also considers equity-related securities including warrants and preferred stocks also pursues preferred equity investments and common equity investments. Within private equity, it seeks to invest in growth, acquisitions, market or product expansion, refinancings and recapitalizations. It seeks to invest in middle market companies based in the United States, with EBITDA between $10 million and $250 million annually and/or annual revenue of $50 million and $2.5 billion at the time of investment.

Full ORCC Calculator →
📬

Get this LSBPW vs ORCC comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

LSBPW vs SCHDLSBPW vs JEPILSBPW vs OLSBPW vs KOLSBPW vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.